TCI Versus Manual TIVA for Sedation During Prone Kyphoplasty: Effects on Respiration, Recovery, and EEG
Investigation of the Effects of Target-Controlled Infusion (TCI) Anesthesia on Respiration, Recovery, and Electroencephalogram in Patients Undergoing Kyphoplasty in the Prone Position
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Kyphoplasty is a minimally invasive spinal procedure commonly performed for osteoporotic vertebral compression fractures. The procedure involves balloon elevation of the collapsed vertebral body followed by injection of polymethylmethacrylate (PMMA) bone cement for stabilization. The procedure is performed in the prone position and typically involves 1-2 vertebral levels.
Total intravenous anesthesia (TIVA), using combinations of propofol and remifentanil, is an alternative to inhalation anesthesia. TIVA can be administered manually or via target-controlled infusion (TCI) systems. TCI systems use pharmacokinetic models to achieve and maintain targeted plasma or effect-site concentrations. Studies in endoscopy settings have demonstrated that TCI-based sedation provides more stable sedation depth, fewer hemodynamic fluctuations, and faster recovery compared to manual administration.
Kyphoplasty procedures are typically performed in elderly patients with multiple comorbidities in the prone position under fluoroscopic guidance. The prone position, while mandatory for kyphoplasty, presents significant anesthesia management challenges: limited airway access increases the risk of respiratory depression during sedation, and chest compression impairs ventilation mechanics and may reduce alveolar ventilation. Therefore, meticulous respiratory monitoring during kyphoplasty is essential.
The Capnostream® device records four variables (SpO₂, respiratory rate, non-invasive EtCO₂, and heart rate) every 30 seconds via a nasal cannula and integrates them into a single unitless value called the Integrated Pulmonary Index (IPI), ranging from 1 to 10. An IPI of 4 or below requires intervention, while 8-10 represents the normal range. Additionally, bispectral index (BIS) monitoring enables objective tracking of anesthesia depth through EEG waveform analysis.
This study aims to compare manual TIVA versus TCI methods regarding sedation depth, respiratory stability, hemodynamic parameters, and recovery in patients undergoing kyphoplasty in the prone position. The findings are expected to contribute to determining the optimal anesthesia approach in this patient population.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: dilara göçmen, asst prof
- Número de teléfono: +90 5413439438
- Correo electrónico: dilara.gocmen@marmara.edu.tr
Ubicaciones de estudio
-
-
Maltepe
-
Istanbul, Maltepe, Turquía (Türkiye), 34854
- Seniyye Ülgen Zengin
-
Contacto:
- seniyye ülgen zengin, assoc prof
- Número de teléfono: +90 216 606 11 41
- Correo electrónico: suzengin@marmara.edu.tr
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Age 18 years and older
- ASA physical status classification I-III
- Scheduled for kyphoplasty under sedation in the prone position
- Provision of written informed consent
Exclusion Criteria:
Known allergy to any of the study medications
- ASA physical status classification IV or higher
- Patients deemed unsuitable for sedation (high pulmonary risk, morbid obesity, diagnosed severe obstructive sleep apnea)
- Refusal to participate or withdrawal of consent
- Diagnosis of dementia or Alzheimer's disease
- Communication difficulties precluding adequate assessment
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
Group TIVA
Patients receiving sedation via conventional manually administered total intravenous anesthesia (TIVA).
Propofol 1% is administered by the anesthesiologist via manual boluses as needed, guided by BIS values, hemodynamic variables, and clinical assessment.
|
The Capnostream® device records four variables (SpO₂, respiratory rate, non-invasive EtCO₂, and heart rate) every 30 seconds via a nasal cannula and integrates them into a single unitless value called the Integrated Pulmonary Index (IPI), ranging from 1 to 10.
An IPI of 4 or below requires intervention, while 8-10 represents the normal range
|
|
group TCI
Patients receiving sedation via target-controlled infusion (TCI) using the Schnider pharmacokinetic model.
Propofol 1% is administered via TCI device with patient-specific parameters (height, weight, age, sex) entered.
Plasma target concentration is titrated between 0.5-3 µg/mL.
Sedation depth is adjusted according to BIS values and hemodynamic responses
|
The Capnostream® device records four variables (SpO₂, respiratory rate, non-invasive EtCO₂, and heart rate) every 30 seconds via a nasal cannula and integrates them into a single unitless value called the Integrated Pulmonary Index (IPI), ranging from 1 to 10.
An IPI of 4 or below requires intervention, while 8-10 represents the normal range
In patients in group TCI, target-controlled propofol sedation will be administered using an elevated (opioid) model, and the target concentration will be titrated between 1-2 mcg/ml.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
. Number of Hypoxic Episodes
Periodo de tiempo: from sedation initiation to end of procedure,Intraoperatively
|
Total number of episodes in which peripheral oxygen saturation drops below 90% during the procedure.(SpO₂
< 90%)
|
from sedation initiation to end of procedure,Intraoperatively
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Anesthesia Quality Score (0-32)
Periodo de tiempo: from sedation initiation to end of procedure, Intraoperatively.
|
Assessed using the Simplified Quality of Anesthesia Scoring System (Ding & White), evaluating motor response, hemodynamic stability, and respiratory stability.
|
from sedation initiation to end of procedure, Intraoperatively.
|
|
Integrated Pulmonary Index (IPI) Values
Periodo de tiempo: Every 10 minutes intraoperatively, during sedation procedures
|
Composite index (1-10) integrating SpO₂, respiratory rate, EtCO₂, and heart rate measured via Capnostream® device.
|
Every 10 minutes intraoperatively, during sedation procedures
|
|
Total Propofol Consumption
Periodo de tiempo: Intraoperatively, from sedation initiation to end of procedure
|
Total amount of propofol administered during the procedure (mg).
|
Intraoperatively, from sedation initiation to end of procedure
|
|
Time to Eye Opening
Periodo de tiempo: From end of procedure to first eye opening, up to 10 minutes
|
Time in minutes from end of the procedure to spontaneous eye opening.
|
From end of procedure to first eye opening, up to 10 minutes
|
|
Surgeon Satisfaction
Periodo de tiempo: end of the procedure.
|
Assessed on a 4-point scale: very good, good, fair, poor.
|
end of the procedure.
|
Colaboradores e Investigadores
Publicaciones y enlaces útiles
Publicaciones Generales
- Ding Y, White PF. Simplified quality of anaesthesia scoring system. Anaesthesia. 1992 Oct;47(10):906-7. doi: 10.1111/j.1365-2044.1992.tb03166.x. No abstract available.
- Sandler NA, Hodges J, Sabino M. Assessment of recovery in patients undergoing intravenous conscious sedation using bispectral analysis. J Oral Maxillofac Surg. 2001 Jun;59(6):603-11; discussion 611-2. doi: 10.1053/joms.2001.23366.
- Chang YT, Tsai TC, Hsu H, Chen YM, Chi KP, Peng SY. Sedation for gastrointestinal endoscopy with the application of target-controlled infusion. Turk J Gastroenterol. 2015 Sep;26(5):417-22. doi: 10.5152/tjg.2015.0206.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- MJR KYPHO
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .